Neurology News

The Residency to Retirement resource center offers insightful and innovative strategies to help physicians reduce taxes, protect assets, invest wisely and build wealth during all phases of their careers.

Cebranopadol, a pain relief drug, showed low potential for abuse among nondependent recreational opioid users compared with tramadol or oxycodone, researchers from Tris Pharma Inc. stated in a press release.

Although cluster headaches may be more common in men, they may be more severe for women, researchers reported in Neurology.

Click Therapeutics announced it has received breakthrough device designation from the FDA for its digital therapeutic, CT-132, as an adjunctive preventive treatment for episodic migraines in those aged 18 years and older.

Individuals with prodromal or unrecognized Parkinson’s disease may have greater impairment involving mobility and strength up to 3 years prior to diagnosis, researchers reported in JAMA Neurology.

On Dec. 8, Grammy award-winning artist Celine Dion announced that she would be rescheduling her 2023 tour dates after being diagnosed with stiff-person syndrome, a progressive neurological disorder.

Genetic-based screening tests among children with epilepsy may provide knowledge into the clinical characteristics of molecular diagnoses of rarer forms of the disorder, researchers found.

Neither mindfulness training nor exercise appeared to have a significant effect on cognitive function, according to results of a randomized clinical trial published in JAMA.

The consumption of walnuts was shown to reduce academic stress and bolster mental health among university students, especially women, researchers reported in Nutrients.

Fresenius Kabi announced the immediate availability of lacosamide injection, an approved treatment option for partial-onset seizures in those aged 17 years and older, in the United States.